Clinical Trials in Boston

Showing 8961-8980 of 17,836 trials

Online Therapy for Posttraumatic Stress Symptoms in WTC Responders and Survivors

NCT03154151

If you worked or volunteered as a WTC rescue, recovery or clean-up worker after the 9/11 attacks, or are a survivor of the WTC 9/11 attacks, and you are still experiencing Posttraumatic Stress Disorder (PTSD) symptoms related to your WTC experience, you might be eligible to participate in this clinical trial of therapist-assisted, Internet-based (online) writing therapy for WTC responders and survivors with persistent PTSD symptoms. This study is for WTC responders and survivors who are not currently receiving psychotherapy/counseling. In this study, the researchers aim to find out if Internet-based therapy can help WTC responders and survivors who are still experiencing PTSD symptoms.

Post-Traumatic Stress Disorder

Icahn School of Medicine at Mount Sinai105 participantsStarted Aug 2017

New Haven, Connecticut, United States • Boston, Massachusetts, United States • New York, New York, United States +1 more locations

COMPLETEDPhase 3< 1 mile

Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia

NCT04362813

This was a multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of canakinumab plus standard-of-care (SOC) compared with placebo plus SOC in patients with COVID-19-induced pneumonia and cytokine release syndrome (CRS).

Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia

Novartis Pharmaceuticals454 participantsStarted Apr 2020

Birmingham, Alabama, United States • Glendale, California, United States • San Francisco, California, United States +36 more locations

Online Therapy for Posttraumatic Stress Symptoms in WTC Responders and Survivors

Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia

Find Trials by Condition in Boston

Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis

Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients

Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE)

COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC

Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)

ExAblate Transcranial MRgFUS of the Globus Pallidum for Treatment of Parkinson's Disease

Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)

Cook IVC Filter Study

Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Myopic Population

A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)

PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma

A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes

Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance

A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06)

UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder

Study of TV-1106 in Growth Hormone-Deficient Adults

Argus® II Retinal Stimulation System Feasibility Protocol

Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment